NDC 54868-4535-0 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4535
- Requested NDC
- 54868-4535-0
- Package NDCs from labels
- 54868-4535-1, 54868-4535-0
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4535-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4535-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4535 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4535-0 | EA - Each | 54868-4535 | b4aef346-caf3-4da3-8d9d-1925e154fab5 | 1 | 2012-07-24 |
| 54868-4535-1 | EA - Each | 54868-4535 | e84f8d98-5131-4014-927f-495343aa1e72 | 1 | 2012-07-24 |
| 54868-4535-2 | EA - Each | 54868-4535 | 2dc70794-405b-4bee-8a56-d732a9fcb6e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ecaa38f-8a6f-4536-8033-251d2c52ae64 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 4461bc9f-35db-4211-82ab-7671cf4dc14b | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 66bb0ba9-cd63-4817-907f-7b8ad5dc6685 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Tirosint SOL | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8ac112c3-1e06-4fdb-a7af-2ee988de5b15 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 69fb5cd6-90ba-487d-a754-07c664a1fdd1 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Rapidol Sodium Bicarbonate | SODIUM BICARBONATE | Pharmadel LLC | b4c9a653-6f51-7c98-e053-2995a90ada37 | 2026-03-26 | Warnings | 8MDF5V39QO |
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | YARAL Pharma Inc. | d28d7202-1278-0486-e053-2995a90af286 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | bba7d5bf-c94b-4ee4-a399-9a2818d84c78 | 2026-03-23 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 991399a4-ff94-44d0-b1ba-1f89e7759498 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 87333260-fe57-4d99-886c-7c66cb063898 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.